TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.59B
AUM Growth
-$205M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1
+$42.8M
2
+$22.8M
3
+$21.8M
4
CELG
Celgene Corp
CELG
+$14.3M
5
NVO icon
Novo Nordisk
NVO
+$10.1M

Top Sells

1
+$25.1M
2
+$24.3M
3
+$23.5M
4
GILD icon
Gilead Sciences
GILD
+$21.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$16.2M

Sector Composition

1 Healthcare 92.75%
2 Real Estate 2.87%
3 Financials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
151
$441K 0.02%
7,441
152
$438K 0.02%
20,000
153
$386K 0.01%
6,300
-70,300
154
$302K 0.01%
27,500
155
$300K 0.01%
7,053
156
$148K 0.01%
23,725
157
$61K ﹤0.01%
1,109
158
– –
-15,000
159
$0 ﹤0.01%
1
-50,444
160
– –
-152,900
161
– –
-56,900
162
– –
-341,471
163
– –
-294,749
164
– –
-48,076
165
– –
-1,034
166
– –
-123,200
3 4 5 6
7